Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
1(8%)
Results Posted
133%(4 trials)
Terminated
3(23%)

Phase Distribution

Ph phase_2
2
15%
Ph phase_3
1
8%
Ph not_applicable
7
54%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

37.5%

3 of 8 finished

Non-Completion Rate

62.5%

5 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(3)
Terminated(5)
Other(2)

Detailed Status

Completed3
Terminated3
unknown2
Withdrawn2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 41 (9.1%)
N/A7 (63.6%)

Trials by Status

not_yet_recruiting18%
completed323%
recruiting18%
unknown215%
withdrawn215%
terminated323%
enrolling_by_invitation18%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT07225751Not Applicable

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

Recruiting
NCT07310082Not Applicable

Allograft vs. Autograft Nonunion

Not Yet Recruiting
NCT07326657Phase 4

Evaluating Whether Intact Fish Skin Graft Can Decrease the Need for Autograft in the Treatment of Deep Partial-Thickness Burns

Enrolling By Invitation
NCT02924571Not Applicable

BMAC & Allograft vs BMP-2

Completed
NCT04855175Not Applicable

Evaluation of Cranioplasty Using Native Bone Autograft Versus Synthetic Bone Allograft

Terminated
NCT05017961Not Applicable

Comparing Efficacy of Bone Marrow Aspirate Concentrate (BMAC) Combined With Allograft in Treatment of Calcaneus Fractures

Withdrawn
NCT05480631Phase 2

COMPARATIVE ANALYSIS OF INNOVATIVE BONE HEALING TECHNIQUES

Unknown
NCT03005054Phase 2

StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects

Terminated
NCT03005106Phase 3

StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements

Completed
NCT00841152

Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute

Completed
NCT00676013Not Applicable

Comparison of Skin Substitutes Used in Burn Care

Terminated
NCT03681938

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

Unknown
NCT02005341Not Applicable

NanOss Bioactive With Autograft and Bone Marrow Aspirate in the Posterolateral Spine

Withdrawn

All 13 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
13